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Safety and Effectiveness of Moderate
Sedation for Radiologic Non-Vascular
Intervention
Objective: The purpose of this study was to prospectively characterize the
safety and effectiveness of moderate sedation/analgesia for performing radiologic
non-vascular abdominal intervention.
Materials and Methods: During a 3-month period, a total of 63 adult patients
with a mean age of 64 years (range: 27 82) underwent moderate sedation for 72
radiologic non-vascular interventional procedures. A combination of fentanyl cit-
rate and midazolam hydrochloride, based on the patient’s body weight, was intra-
venously administered until the patient was drowsy and tranquil. The adverse
events associated with this moderate sedation were assessed. The visual analog
scale format was used to measure the subjective feelings of the patient’s pre-pro-
cedural anxiety and intraprocedural pain.
Results: The mean total dose per kilogram of body weight of fentanyl used in
PTBD was 1.148 g, it was 1.157 g for PTGBD, 1 g for AD, 1 g for PCN, 1.641 g
for TDC, 1 g for DJS, 2 g for BS, 1 g for GS and 2 g for RFA. The mean total
dose per kilogram of body weight of midazolam was 0.035 mg in PTBD, PTGBD,
AD, PCN, DJS, GS and RFA, 0.039 mg in TDC, and 0.043 mg in BS. A tempo-
rary reduction of systolic blood pressure to less than 80 mmHg was observed
during 5 procedures (6.9%), whereas a temporary elevation of systolic blood
pressure above 150 mmHg was observed during 10 procedures (13.8%). A
reduction of arterial oxygen saturation to less than 90% was observed during 14
procedures (19.4%). None of the patients required pharmacologic reversal
agents or cardiopulmonary resuscitation. The mean anxiety score recorded
before all procedures was 5.2 (distressing). The mean pain score during the pro-
cedure, which was recorded after all procedures, was 2.9 (mild). 
Conclusion: Moderate sedation allows performance of safe and effective radi-
ologic non-vascular intervention, and it is also easy for an interventional radiolo-
gist to use. The patients should be continuously monitored to check their vital
signs and arterial oxygen saturation during the procedures.
erforming invasive therapeutic procedures in an interventional radiology
suite can be painful and anxiety-provoking (1 5). It may be necessary to
provide pharmacologic sedation and analgesia to decrease the patients’
anxiety, reduce unwanted movements and to alleviate the patients’ discomfort (6).
However, achievement of safe and effective sedation and analgesia during interventional
procedures is challenging and most radiologists have no formal training for this (7).
Radiologists are often poorly informed about the drugs they use and the potential life-
threatening problems that are associated with the induction of anesthesia due to drug
synergism (8). Although anesthesiologists are the best equipped to provide sedation and
analgesia, they are usually not available to attend all radiologic interventional procedures;
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Pthe responsibility of administering medication and patient
care often falls on the shoulders of the interventional radiolo-
gist. However, the provision of sedation and analgesia by
properly trained non-anesthesiologists is thought to be safe, if
the proper methods of drug administration and patient
monitoring are adhered to (6, 9 13). Moderate sedation
provides sufficient anxiolysis and control of unwanted
movements during most radiologic interventional procedures
(6). The purpose of this study is to prospectively evaluate the
safety and effectiveness of moderate sedation/analgesia, as
performed by an interventional radiologist, during radiologic
non-vascular abdominal intervention.
MATERIALS AND METHODS
All the patients who underwent radiologic non-vascular
interventional procedures at our clinic during a 3-month
period were asked to participate in this study. Patients were
excluded from the study if (a) they were younger than 18
years, (b) they had received a sedative or analgesic within 4
hours before the procedure, (c) the procedure was
performed on night duty, and (d) the patient was in a
critically ill state such as having a systolic blood pressure
less than 80 mmHg. A total of 63 adult patients (29 females
and 34 males; mean age: 64 years; age range: 27 82 years)
fit the selection criteria and they underwent moderate
sedation for radiologic non-vascular interventional
procedures. The following 72 radiologic non-vascular
interventional procedures were performed in 63 adult
patients: percutaneous transhepatic biliary drainage (PTBD,
n = 21), percutaneous transhepatic gallbladder drainage
(PTGBD, n = 13), percutaneous abscess drainage (AD, n =
10), percutaneous nephrostomy (PCN, n = 10), PTBD track
dilatation for choledochoscopy (TDC, n = 10), implanting a
ureteral double J stent (DJS, n = 3), implanting a biliary
stent (BS, n = 2), implanting a gastric stent (GS, n = 2), and
radiofrequency ablation of hepatocellular carcinoma (RFA,
n = 1). Two different procedures were performed in nine
patients at different times: PTBD (n = 7) prior to TDC (n =
6) and BS (n = 1), and PCN (n = 2) prior to DJS (n = 2).
All patients who underwent percutaneous procedures
received a local skin anesthetic of 5~15 mL of 2% lidocaine
(Huons, Hwaseong, Korea). The moderate sedation
protocol mainly followed the staged-dose system proposed
by Skehan et al. (7). The drugs were administered just
before the procedure by nurses under the direction of the
radiologist. Fentanyl citrate (Guju Pharm. Co., Hwasung,
Korea) and midazolam hydrochloride (Roche, Fontenay-
sous-Bois, France) were administered intravenously as a
slow (30 60 second) bolus infusion in one to five steps (A,
B, C, D, E) until the patient was drowsy and tranquil (7).
The doses per step were follows: A, fentanyl at 1 g per
kilogram of body weight; B, midazolam at 0.035 mg/kg; C,
fentanyl at 1  g /kg; D, midazolam at 0.015 mg/kg; E,
midazolam as 1 2 mg boluses (maximum: 0.15 mg/kg) (7).
The desired end point of sedation was drowsiness, tranquil-
ity and a reduced sensitivity to pain (7). The correct level of
sedation had been achieved when the patient rested with
their eyes closed, but the patient responded to verbal
commands or mild physical stimulation; this was a state of
moderate sedation (14). We used the first dose of fentanyl
to estimate the lead time in our patient. The lead time is the
time lapse between the drug injection and the clinical effect.
We waited one lead time before proceeding with the next
step in the protocol. We titrated the administration of the
drug for effect and we stopped the administration of drug
when moderate sedation was achieved. We evaluated the
duration of the lead time in each procedure. 
An interventional radiologist and radiology nurses were
designated to monitor each patient and record the clinically
important data on a standard form. A pulse oximeter was
used to continuously monitor arterial oxygen saturation and
ECG, while the blood pressure was automatically measured
every 3 minutes. If the oxygen saturation decreased to
between 90% and 95%, the patient was asked to take deep
breaths. If the saturation decreased to 90% or less, supple-
mental oxygen was administered at a rate of 4 L/minute via
a nasal cannula. As the doses of fentanyl citrate and
midazolam hydrochloride were administered, the individual
and cumulative doses were recorded on the procedural
record form. Standard cardiopulmonary resuscitation
equipment was available if needed. Reversal agents for the
fentanyl (Naloxone hydrochloride, Samjin Pharm. Co. Ltd.,
Seoul, Korea), and midazolam (Flumazenil, Roche, Basel,
Switzerland) were available during all procedures.
A visual analog scale, graded from 0 to 10, was used to
measure the subjective feelings of anxiety and pain. The
interventional radiologist questioned the patient about their
pre-procedural anxiety before the procedure and about their
their intraprocedural pain after the procedure. He asked the
patients to describe their anxiety and pain with standardized
adjectives that corresponded to numerical scores as follows:
0, none; 1 2, mild; 3 4, discomforting; 5 6, distressing;
7 8, horrible; and 9 10, excruciating. The differences in
drug doses and the pain scores between the procedures were
tested using one-way analysis of variance. A p-value of less
than .05 indicated a statistically significant difference. 
RESULTS
The mean procedure time, from the time of drug injection
until the radiologist removed his surgical gloves just after
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The mean total dose of fentanyl used per kilogram of body
weight was 1.148  g in PTBD, 1.157  g in PTGBD , 1  g in
AD, 1  g in PCN, 1.641  g in TDC, 1  g in DJS, 2  g in BS,
1  g in GS and 2  g in RFA (Table 1). The mean total dose
per kilogram of body weight of midazolam was 0.035 mg in
PTBD, PTGBD, AD, PCN, DJS, GS and RFA, 0.039 mg in
TDC and 0.043 mg in BS (Table 1). Significantly more
fentanyl was required in the TDC procedure than in the
PTBD, PTGBD, AD and PCN (p < .05). The dose of
midazolam administered was not significantly different
between the procedures. The number of required steps in
the ABCDE protocol to achieve the moderate sedation is
illustrated in Table 2. No patient was adequately sedated
after step A, while 57 procedures were sufficiently drowsy
after step B, 11 procedures after step C and four procedures
after step D (Table 2). The duration of the lead time in each
procedure was 2 5 minutes (mean: 3.8 minutes).
The mean anxiety score recorded before all procedures
was 5.2 (distressing). The mean pain score during the
procedure, which was recorded after all procedures, was
2.9 (mild). Figure 1 illustrates the distribution of the pre-
procedural anxiety scores and the intraprocedural pain
scores for all 72 procedures. Pain scores of 4 or less were
recorded in 68 (94.4%) procedures. Four patients
complained of pain scores greater than 5 during TDC
(three patients) and BS (one patient). These patients
received an incremental dose of sedative or analgesic and
an incremental dose of lidocaine.
Patients received supplemental oxygen (4 L/min) via a
nasal cannula in 14 (19.4%) of 72 procedures due to an
arterial oxygen saturation level of less than 90%. Patients
with an arterial oxygen saturation level between 90% and
95% were asked to take deep breaths in 11 (15.3%) of 72
procedures. All patients with arterial oxygen desaturation
responded promptly to an increase in inspired oxygen.
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Table 1. Procedures and the Drug Doses
Procedures Mean BW (kg) Mean Total Dose of  Mean Total Dose of F  Mean Total Dose of  Mean Total Dose of M   
F ( ) per kg of BW ( /kg) M (mg) per kg of BW (mg/kg)
PTBD 54 062 1.148 1.9 0.035
PTGBD 51 059 1.157 1.8 0.035
AD 59 059 1 2.1 0.035
PCN 54 054 1 1.9 0.035
TDC 61 100 1.641 2.4 0.039
DJS 63 063 1 2.2 0.035
BS 36 072 2 1.7 0.043
GS 50 050 1 1.8 0.035
RFA 50 100 2 1.8 0.035
Note. BW = body weight, F = fentanyl, M = midazolam, PTBD = percutaneous transhepatic biliary drainage, PTGBD = percutaneous transhepatic
gallbladder drainage, AD = percutaneous abscess drainage, PCn = percutaneous nephrostomy, TDC = PTBD track dilatation for choledochoscopy, DJS =
ureteral double J stent, BS = biliary stent, GS = gastric stent, RFA = Radiofrequency ablation of hepatocellular carcinoma 
Table 2. The Number of Steps Required to Achieve the Moderate Sedation 
Proceures A A+B A+B+C A+B+C+D A+B+C+D+E
PTBD (21)  18 03
PTGBD (13) 11 02
AD (10) 10
PCN (10) 10
TDC (10) 03 043
DJS (3) 03
BS (2) 011
GS (2) 02
RFA (1) 01
Total (72) 0 57 11 4 0
Note. A, fentanyl 1 /kg; B, midazolam 0.035mg/kg; C, fentanyl 1 /kg; D, midazolam 0.015 mg/kg; E, midazolam 1 2 mg boluses,
PTBD = percutaneous transhepatic biliary drainage, PTGBD = percutaneous transhepatic gallbladder drainage, AD = percutaneous
abscess drainage, PCn = percutaneous nephrostomy, TDC = PTBD track dilatation for choledochoscopy, DJS = ureteral double J stent,
BS = biliary stent, GS = gastric stent, RFA = Radiofrequency ablation of hepatocellular carcinoma, (  ) = numberNone of the patients required pharmacologic reversal of
the sedation because of hypoxia.
In 5 PTBD procedures, the systolic blood pressure
temporarily decreased to less than 80 mmHg during the
procedure. In all of these patients, the temporal reduction
of blood pressure was related to drug administration and
the blood pressure decreased when the sedatives were
administered. In 10 procedures, the systolic blood pressure
increased to more than 150 mmHg during a painful portion
of the following procedures: 2 PTBD, 3 TDC, 2 PTGBD, 2
PCN and 1 BS. All of the hemodynamic changes responded
to increased intravenous fluid and/or to an incremental
dose of sedative, analgesic or local anesthetic. None of the
patients required cardiopulmonary resuscitation. 
DISCUSSION
When performing procedures, interventional radiologists
are responsible for administering safe, effective sedation
and analgesia. A 1993 survey of interventional radiologic
practices in the British Isles (15) showed that anesthesiolo-
gists were present for less than 10% of procedures. Even
when patients are critically ill, most interventional
procedures are performed without the assistance of
anesthesiologists (7). General guidelines have been
published on the use of sedation by non-anesthesiologists
(10), but no consensus exists for a single drug administra-
tion protocol that is suitable for the majority of interven-
tional radiologic cases (7). Generally, benzodiazepines
(BZDs) and opioids are used to achieve safe and effective
sedation and analgesia during radiologic interventional
procedures. Proper use of these agents improves the
patient’s satisfaction, reduces the procedure time and
stabilizes the hemodynamic status; however, incorrect drug
administration or inadequate patient monitoring can
precipitate disastrous complications and even death (16
18). All the sedation procedures done in this study were
performed by an interventional radiologist with the
support of radiology nurses. Midazolam, a short-acting
BZD, and fentanyl, a short-acting opioid, were used in this
study as a sedative and analgesic, respectively.
Midazolam is a short-acting BZD (6). The onset of its
effect is within 2 minutes, and it lasts between 45 and 60
minutes (6). The short-acting sedative effect with rapid
recovery, the low risk of respiratory depression, and the
antegrade amnestic effects associated with midazolam
make it the favored sedative agent used by non-anesthesi-
ologists to achieve moderate sedation during radiology
procedures (19). Although this agent is relatively safe,
more than 80 deaths have been reported after midazolam
use for patients undergoing a variety of medical and
surgical procedures (6). Apnea may occur with rapid
injection of midazolam (10). The effects of midazolam can
be quickly reversed with flumazenil. 
Fentanyl is a short-acting opioid (6). The onset of its
effect is 2 3 minutes, and the duration of the analgesic
effect is between 30 and 60 minutes (6). Fentanyl is
favored by most physicians over the other opioids when
performing short, painful procedures because of its rapid
onset and suitable duration of effect (6). Its principal
adverse effect is profound respiratory depression due to
depression of the carbon dioxide response and elimination
of the hypoxemia response (10). The effects of fentanyl are
rapidly reversed with naloxone hydrochloride. The mean
procedure time in this study was 41 minutes. The durations
of the effects of midazolam and fentanyl were quite
adequate since less than 60 minutes was required for most
of our non-vascular interventional procedures. The rapid
onset of action was also advantageous. 
When used in combination, fentanyl and midazolam
provide effective analgesia, sedation and amnesia (15, 20
22). However, the two drugs have synergistic effects on
respiration (18). As of 1989, there were reports of 49
deaths due to the use of midazolam and opiates in the
United States (18). Respiratory depression or apnea is
common during moderate sedation. 
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Fig. 1. The pre-procedural anxiety is mainly distributed in the mid-
scores (distressing) and the intraprocedural pain is mainly distrib-
uted in low-scores (mild). (Note: 0, none; 1 2, mild; 3 4,
discomforting; 5 6, distressing; 7 8, horrible; and 9 10,
excruciating)
preprocedural anxiety
intraprocedural painModerate Sedation 
Sedation refers to the use of pharmacologic and non-
pharmacologic means to depress the central nervous
system and to reduce patient anxiety and irritability (23).
Analgesia is defined as the relief of pain without the
intentional production of an altered mental state, the same
as in sedation (23). Moderate sedation/analgesia is the
depression of consciousness during which time the patients
respond purposefully to verbal commands, either alone or
the commands are accompanied by light tactile stimulation
(6). The patient maintains airway patency and spontaneous
ventilation, and the cardiovascular function is usually
maintained. Moderate sedation provides sufficient anxioly-
sis and control of unwanted movements during most
interventional radiology procedures (6). This level of
sedation is therefore an appropriate target for procedures
that are not supervised by an anesthesiologist. The term
conscious sedation continues to be used in both the
anesthesia and non-anesthesia literature (6). However, this
term is no longer included in standards of the American
Society of Anesthesiologists (ASA) (10), and its use is
being discouraged because it is imprecise and potentially
misleading (24 26). 
To achieve moderate sedation in this study, the drugs
were administered in a stepwise fashion according to the
staged-dose system proposed by Skehan et al. (7). The
mean total dose of fentany and midazolam used in each
procedure to achieve the moderate sedation was 68  g
(range, 54 100  g) and 1.9 mg (range, 1.7 2.4 mg)
respectively. No patient was adequately sedated after step
A, while the majorities were sufficiently sedated after step
B to commence the procedure (Table 2). 
Safety
Fentanyl and midazolam may be the ideal drugs for use
in many interventional procedures because they have a
rapid onset of action (usually less than 3 minutes) and a
short duration of effect (usually less than 60 minutes).
However, it is unwise to administer both of them simulta-
neously since they act synergistically (14, 18, 20). The
principal concerns with the combination of fentanyl and
midazolam are hypoxemia and/or respiratory arrest (7). In
one study (18), fentanyl administered at a dose of 2  g/kg
body weight produced hypoxia (oxygen saturation < 90%)
in six of 12 healthy volunteers. The addition of midazolam
at a dose of 0.05 mg/kg body weight increased the
incidence of hypoxia to 11 (92%) volunteers (18). There is
great inter-patient variation in susceptibility to these drugs
and the concept of stepwise administration to achieve
moderate sedation is a logical way to avoid hypoxia in the
more susceptible patients (10). 
No patient became apneic in this study. The important
role of the radiology nurse is to detect bradypnea and
apnea. This is consistent with the guidelines of the ASA,
which recommends that “the ventilatory function should
be continually monitored by observation” (10). We consid-
ered an oxygen saturation of less than 90% to be indica-
tive of clinically significant hypoxemia. Below this level,
further desaturation occurs along the steep portion of the
oxyhemoglobin dissociation curve, and this causes a
greater risk of hypoxia-related complications such as
cardiac and cerebral ischemia, and arrhythmia (10). We
stopped all the procedures when the oxygen saturation fell
to 90% and we then administered supplemental oxygen at
a rate of 4 L/minute via a nasal cannula to prevent
clinically significant hypoxemia. The oxygen saturation
decreased to 90% or lower in only 14 (19.4%) procedures,
and all these patients improved after the administration of
supplemental oxygen. In the study by Skehan et al. (7), the
oxygen saturation decreased to 90% or lower in only 15
(13%) patients. Continuous monitoring of the oxygen
saturation and blood pressure are essential for all patients
and if possible, the administration of supplemental oxygen
is recommended for all patients. Also, reversal agents must
be available during all procedures.
Effectiveness
The patients during 68 (94.4%) procedures described pain
scores of 4 or less on a scale of 0 to 10 (Fig. 1), with a score
of 4 being indicative of discomforting pain. This score
represented an acceptable level of analgesia. In total, four
patients complained of pain scores in excess of 5 during
TDC (three patients) and BS (one patient). Although the
patients appeared to have been moderately sedated, they
suddenly indicated pain; this occurred mainly during track
dilatation for choledochoscopy, which is often a very painful
procedure. Additional drugs were administered in a stepwise
fashion to achieve moderate sedation subsequent to the
painful episodes. Significantly more fentanyl was required
during the TDC procedure than during the other procedures.
A few other studies have reported on the effectiveness of
analgesia during interventional radiologic procedures. Ayre-
Smith (22) described achieving “favorable results” with
fentanyl and midazolam in a preliminary report of 12
patients who underwent unspecified interventional
radiologic procedures. Miller and Wall (27) reported
effective analgesia in all 100 patients who underwent
sedation and analgesia for radiologic procedures with a
combination of fentanyl and diazepam. In one large study
on pain control during interventional biliary procedures (2),
epidural anesthesia was effective in 91% of the cases, while
intravenous sedation was successful in only 50%. However,
Moderate Sedation for Radiologic Non-Vascular Intervention
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sedation because most of the patients received single-agent
therapy with a narcotic such as meperidine or morphine,
without the synergistic benefit of a benzodiazepine. 
It is important to stress that the effective use of local
anesthetic is a vital component of interventional radiology,
and particularly for percutaneous non-vascular interven-
tion. Sufficient infiltration with a local anesthetic may
markedly reduce the requirement for sedation and
analgesic (28). Sufficient use of a local anesthetic may have
substantially reduced the pain associated with track dilata-
tion in the three patients of this study for whom the pain
was poorly controlled. 
The major limitation of this study was that we didn’t
make comparisons with the control groups such as a group
using only lidocaine as a local anesthetic and a group using
only demerol as a analgesic. Another limitation was the
small number of cases of DJS, BS, GS and RFA; thus, these
procedures were excluded from the statistical analysis.  
In conclusion, moderate sedation during radiologic non-
vascular intervention is both safe and effective. Moderate
sedation is easy to achieve in patients and it is useful for
interventional radiologists. However, all patients undergo-
ing moderate sedation should be continuously monitored
to check the vital signs and arterial oxygen saturation.
Administering supplemental oxygen is also recommended
for all patients, if possible. 
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